Valneva SE - Company Profile
Powered by
All the data and insights you need on Valneva SE in one report.
$295
- Save hours of research time and resources with
our up-to-date Valneva SE Strategy Report
- Understand Valneva SE position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Valneva SE’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
05 Feb 2024 | Valneva Sells Priority Review Voucher for USD103 Million | Asset Transaction | - |
Valneva SE |
03 Jul 2023 | NorthX Biologics Acquires Clinical Trial Manufacturing Unit from Valneva | Asset Transaction |
NorthX Biologics Matfors AB
|
Valneva Sweden AB
|
28 Sep 2022 | Valneva Raises USD96.55 Million in Private Placement of Shares | Equity Offering | - |
Valneva SE |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer